权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Charting a New Course for Heart Failure: From Discovery to Data

制定心力衰竭新路线：从发现到数据

基本信息

批准号：
9914527
负责人：
Thale Cross Jarvis
金额：
$ 2.01万
依托单位：
KEYSTONE SYMPOSIA
依托单位国家：
美国
项目类别：
财政年份：
2020
资助国家：
美国
起止时间：
2020-01-01 至 2020-12-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/9914527
关键词：
Address Affect Age Artificial Intelligence Basic Science Biology Biomedical Engineering Cardiac Cardiovascular system Clinical Clinical Research Clinical Sciences Colorado Data Discipline Disease Educational workshop Epigenetic Process Etiology Exercise Exercise Physiology Female Future Genetic Goals Hearing Heart failure Hypertrophy Iatrogenesis Immunology Industry Joints Machine Learning Medical Genetics Medicine Metabolism Methodology Morbidity - disease rate Prevalence Refractory Regenerative Medicine Research Research Personnel Science Scientist Speed Therapeutic bench to bedside clinical translation coronary fibrosis effective therapy epigenomics frontier global health innovation insight interest large datasets learning network molecular phenotype mortality multidisciplinary next generation patient population posters programs research and development success symposium

项目摘要

ABSTRACT Support is requested for a Keystone Symposia conference entitled Charting a New Course for Heart Failure: From Discovery to Data, organized by Drs. Mansoor Husain, Benoit G. Bruneau and Marc Pfeffer. The conference will be held in Keystone, Colorado from March 1-5, 2020. Heart failure is global health problem of increasing prevalence, high morbidity, and refractory mortality, for which there have been relatively few impactful therapeutic advances. This unique multidisciplinary conference will bring together leading clinicians and scientists to share the latest insights on genetic, environmental, iatrogenic and pathophysiological mechanisms of heart failure. The program includes specific sessions and workshops focused on advances in cardiac fibrosis, immunology, metabolism, regenerative medicine, biomedical engineering, and analytical approaches to large datasets of relevance to this disease. Although the program is diverse, each session will address a scientific frontier in heart failure biology of potential therapeutic relevance and will be framed to address an unanswered, important clinical question. This innovative format is purposefully planned to highlight translational opportunities in heart failure and to provide a forum that encourages dialogue between cardiovascular researchers and trainees with distinct perspectives, but who share a common goal of making an impact in heart failure. This conference will be paired with “New Insights into the Biology of Exercise.” These two Keystone Symposia conferences will share a joint session examining exercise physiology and how it affects cardiac energetics and hypertrophy, which will be of interest to audiences attending either conference.

摘要